I[ntegrins]{.smallcaps} comprise a large family of heterodimeric receptors that mediate the adhesion of cells to extracellular matrices and other cells ([@B5]; [@B31], [@B32]; [@B56]; [@B22]; [@B27]; [@B67]; [@B78]). In addition, they are involved in transducing extracellular signals into the cell ([@B32]; [@B35]; [@B20]). Both the α and β subunits of integrins have a large extracellular portion, a transmembrane segment, and generally a short cytoplasmic domain. The cytoplasmic domains of integrins interact with the cytoskeleton and possibly with signaling molecules, but the molecular mechanisms of these interactions are not well understood.

The α~6~β~4~ integrin is a basement membrane receptor for laminins ([@B36]; [@B8]; [@B63],*b*; [@B41]) that engages in cytoplasmic interactions distinct from those of all other known integrins. Instead of being localized at adhesion plaques that serve as anchoring structures of actin filament networks, this receptor is part of hemidesmosomes ([@B6]; [@B70]; [@B34]; [@B65]), junctional complexes that anchor cytokeratin intermediate filament (IF)^1^ networks and mediate adhesion of epithelial cells to the underlying basement membrane. The intracellular interactions of integrin α~6~β~4~ are mediated by the β~4~ subunit, the intracellular portion of which is much larger (∼1,000 amino acids) than that of all the other known β subunits (∼50 amino acids) and bears no apparent sequence homology to them ([@B30]; [@B72]; [@B74]). It contains four regions with homology to fibronectin type III (FNIII) repeats, arranged in two pairs separated by a 143--amino acid-long connecting segment. This large cytoplasmic tail of integrin β~4~ is required, and probably sufficient, for incorporation of the integrin into hemidesmosomes. Specifically, a minimal region on the integrin β~4~ subunit located in the linking segment between the second and third repeat has been reported to be critical to its localization in hemidesmosomes ([@B45]). The targeted inactivation of the integrin β~4~ gene in mice convincingly demonstrated that hemidesmosome formation and proper skin attachment to the basal lamina are crucially dependent on the expression of this integrin subunit ([@B10]; van der Neut et al., 1996).

Cytoplasmic components of the hemidesmosome that have been implicated in the attachment of IFs to this adhesion structure include the bullous pemphigoid antigen 1 ([@B68]), also referred to as BP230 or BPAG1e ([@B82]), plectin ([@B79]), the 200-kD 6A5 antigen (P200; [@B39]), HD1 ([@B48]; [@B29]), and the IF-associated protein 300 ([@B60]). Among these, plectin, IF-associated protein 300, and HD1 have been shown to bind to IFs in vitro ([@B14]; [@B60]; [@B16]), and the IF-binding site of plectin has recently been mapped to the fifth repeat domain within the carboxy-terminal globular region of the molecule ([@B47]). Also, BP230, which shares partial sequence homology with plectin and desmoplakin and is structurally related to these molecules ([@B75]; [@B25]; [@B38]), is likely to bind to IFs ([@B82]). A direct interaction of the intracellular domain of the integrin β~4~ subunit with any of the cytoplasmic hemidesmosome-associated proteins has not been demonstrated to date. There is evidence that integrin β~4~ interacts with HD1, based on coimmunoprecipitation of purified recombinant integrin β~4~ polypeptides expressed in bacteria with HD1 present in COS-7 cell lysates, and the observation that overexpression of integrin β~4~ leads to a redistribution of HD1 in transfected cells ([@B57]; [@B45],*b*), but the question whether this interaction was of direct or indirect nature remains unsolved.

Plectin, the most versatile cytoskeletal linker protein characterized to date, remains a strong candidate for bridging cytokeratin filament networks to hemidesmosomes. In fact, due to the very large size (\>500 kD) of plectin molecules predicted on the basis of cDNA sequencing ([@B80]; [@B42]; [@B12]), and their extended (∼200-nm-long) multi-domain structure, as visualized by electron microscopy ([@B13]), plectin molecules would have the dimensions to span the entire tripartite structure characteristic of hemidesmosomes. In this way, they could extend from the plasma membrane, the location of integrin β~4~, to the filament anchorage site at the hemidesmosome inner plate structure. A role of plectin in hemidesmosome stabilization by physical linkage of proteins constituting this multi-component complex appears likely also in light of recent studies showing that defects in plectin expression lead to epidermolysis bullosa simplex (EBS)-MD, a severe hereditary skin blistering disease combined with muscular dystrophy ([@B7]; [@B18]; [@B44]; [@B51]; [@B61]). Moreover, plectin-deficient mice generated by targeted gene inactivation showed severe skin blistering and degeneration of keratinocytes, apparently caused by a significant reduction in number and mechanical stability of epidermal hemidesmosomes ([@B2]).

The aim of the work presented here was to extend the human disease and plectin gene-knockout studies to the molecular level, and to investigate whether plectin directly interacts with integrin β~4~, and if so, to define the molecular domains of both proteins involved in this interaction. In addition, we were interested in the consequences that overexpression of integrin β~4~ mutant proteins containing putative plectin-binding sites might have on the integrity of cytokeratin filament networks and on the subcellular distribution of plectin. We show here that partially truncated versions of the integrin β~4~ cytoplasmic domain expressed in bacteria bind to recombinant carboxy- and amino-terminal domains of plectin in two independent in vitro binding assays, and that protein species shown to interact in vitro colocalized when ectopically coexpressed in living cells. In addition, we observed self-association of integrin β~4~ mutant proteins in vitro, and show that plectin proteins can modulate this effect. Furthermore, carboxy-terminal integrin β~4~ mutant proteins lacking plasma membrane anchoring sequences, but comprising plectin-binding region(s) in their tail domain, are shown to cause bundling and collapse of IF network arrays upon overexpression in PtK2 and 804G cells, and similar fragments dislocated endogenous plectin from hemidesmosomes in 804G cells.

Materials and Methods {#MaterialsMethods}
=====================

cDNA Constructs
---------------

### Integrin β~4~.

The integrin β~4~ subunit protein and cDNA sequences were numbered according to Suzuki and Naitoh (1990; Genbank/EMBL/DDBJ accession number [X51841](X51841)). Nucleotide and primer numbers refer to the nucleotide position (3′) relative to the first bp of the start codon (position 127 in [X51841](X51841)). For cloning, a part of the cytoplasmic tail region of integrin β~4~ was amplified by PCR from human placenta cDNA (Quick-Clone; CLONTECH Laboratories, Inc., Palo Alto, CA) using primers U3330 (5′-GAG CTT CAC GAG TCA GAT GTT GTC-3′) and L5250 (5′-GGG GCA GGG TGC GGT CAA GTT TGG-3′). A mixture of Klen-Taq (AB Peptides, St. Louis, MO) and PfuI (Stratagene, Heidelberg, Germany) polymerases was used under high fidelity conditions described by [@B3]. The 1944 bp PCR product obtained was used as template for nested PCR with EcoRI-tailed primers and the amplified fragments were subcloned into the unique EcoRI site of the bacterial expression vector pBN120 ([@B47]), a derivative of pET-15b (Novagen Inc., Madison, WI). Clones generated encoded the following domains of the integrin β~4~ subunit: β~4~-F~1,2~ (amino acid residues 1,126--1,315; plasmid construct pGR1), β~4~-L (1,316--1,457; pGR2), β~4~-F~3,4~C′(1,486--1,752; pGR3), β~4~-F~2~L (1,219--1,457; pGR4), β~4~-F~1,2~L′(1,126--1,485; pGR5), and β~4~-F~1,2~LF~3,4~C (1,126--1,752; pGR6). The clone encoding β~4~-F~3,4~ (1,457--1,662; pJP5) was generated by PCR from pGR6 (β~4~-F~1,2~LF~3,4~C; see Fig. [1](#F1){ref-type="fig"} *A* for an overview). The correctness of all PCR-generated clones was verified by DNA sequencing. The clone encoding β~4~-F~1,2~L (1,126--1,457; pGR36) was obtained by exchanging the SmaI/PstI fragment from pGR5 with that of pGR4. Plasmids encoding β~4~-LF~3,4~C (1,316--1,752; pGR37) and β~4~-F~3,4~C (1,457--1,752; pGR44) were constructed by exchanging the SmaI/HindIII fragment of pGR2 with that of pGR6 and the XbaI/NotI fragment of pGR6 with that of pJP5, respectively. For expression of carboxy terminally c-*myc*--tagged proteins in mammalian cells, EcoRI fragments were subcloned into pAD29 ([@B47]), and excised XbaI/HindIII fragments were subcloned into the eukaryotic expression vector pRc/ CMV (Invitrogen Corp., San Diego, CA). This yielded the mammalian expression constructs encoding β~4~-F~3,4~C′*^myc^* (pGR13, derived from pGR3), β~4~-F~1,2~ *^myc^* (pGR16, derived from pGR1), β~4~-F~1,2~L′*^myc^* (pGR19, derived from pGR5), and β~4~-F~1,2~LF~3,4~C*^myc^* (pGR20, derived from pGR6). In addition, the EcoRI fragment from pGR6 was also subcloned into the eukaryotic expression vector pGR29, a modified version of pEGFP-N3 (CLONTECH Laboratories, Inc.). The resulting protein encoded by this construct (β~4~-F~1,2~LF~3,4~C^GFP^; pGR30) carried an enhanced version of the *Aequorea victoria* green fluorescent protein (GFP) at its carboxy terminus. Correct expression of proteins encoded by mammalian vector constructs was verified by Western blot analysis of lysates of transfected 804G cells.

### Plectin.

Rat plectin cDNA constructs were generated by PCR and/or other cloning techniques on the basis of the complete rat cDNA sequence (Genbank/EMBL/DDBJ database entry [X59601](X59601)). All constructs used were subcloned into the bacterial expression vector pBN120 ([@B47]), which enabled expression of amino terminally his-tagged proteins, except for the ones encoding Ple-N~1~ (pGR48) and Ple-R~3-6~T (pGR49), which were inserted into the unique EcoRI site of pFS23, a pET23a derivative driving the expression of carboxy terminally his-tagged proteins. Plectin constructs encoded the following segments of the protein (see Fig. [1](#F1){ref-type="fig"} *B* for an overview): Ple-N~1~ (amino acids 1--1,128; construct pGR48), Ple-N~2~ (546--1,128; pMZ4), Ple-R~1~ (2,777--3,161; pJD11), Ple-R~1-3~ (2,777--3,851; pJD22), Ple-R~3-6~T (3,346--4,687; pGR49), Ple-R~3~ (3,346--3,851; pJD21), Ple-R~4-6~T (3,850--4,687; pJD23), Ple-R~4,5~ (3,780--4,367; pMZ3), Ple-R~4~ (3,780--4,024; pBN135), Ple-R~5~ (4,025--4,367; pBN132), Ple-R~6~T (4,262-- 4,687; pMZ5), and Ple-R~6~ (4,277--4,620; pBN144). For expression in mammalian cells, EcoRI fragments of pGR48 (Ple-N~1~) and pGR49 (Ple-R~3-6~T) were subcloned into the eukaryotic expression vector pGR29, resulting in constructs encoding GFP-tagged Ple-N~1~ ^GFP^ (pGR31) and Ple-R~3-6~T^GFP^ (pGR33). The latter plectin fragment was also expressed as a c-*myc*-tagged version (Ple-R~3-6~T*^myc^*), encoded by pBN72, a pRc/CMV derived plasmid.

Cell Culture, DNA Transfection, and Immunofluorescence Microscopy
-----------------------------------------------------------------

Rat kangaroo PtK2 (CCL 56; American Type Culture Collection, Rockville, MD) and rat bladder carcinoma 804G cells ([@B33]) were cultured in DME, supplemented with 50 U/ml penicillin, 50 μg/ml streptomycin, and 10% of heat-inactivated fetal calf serum, at 37°C and 5% CO~2~. For transfection, cells were grown on glass coverslips and, while still subconfluent, transiently transfected with either 30 μg plasmid DNA per 10-cm plate using the calcium phosphate precipitation method ([@B23]) or 0.6 μg plasmid DNA per 13-mm coverslip in wells of 24-well tissue culture plates (Falcon Plastics, Cockeysville, MD) using the LipofectAMINE (GIBCO BRL, Paisley, Scotland) transfection method. In the latter case, the transfection medium (0.6 ml/coverslip) contained DNA and LipofectAMINE at final concentrations of 1 μg/ml and 8 μg/ml, respectively, in serum-free medium (Opti-MEM, GIBCO BRL); it was replaced with DME/10% FCS after 4.5 h of incubation at 37°C and 5% CO~2~. Cells were fixed 24--48 (PtK2) or 8--24 h (804G) after transfection using chilled (−20°C) methanol and processed for immunofluorescence microscopy as previously described ([@B81]). The following immunoreagents were used: rabbit anti--human β~4~-antiserum ([@B21]; kindly provided by F.G. Giancotti), mouse monoclonal anti--rat plectin antibody (mAb) 5B3 ([@B15]), guinea pig anti--mouse liver cytokeratin antibody ([@B9]; kindly provided by H. Denk), mouse monoclonal anti-vimentin antibody (clone V9; DAKOPATTS, Copenhagen, Denmark), and anti-*myc* monoclonal antibody 1-9E10.2 (American Type Culture Collection) as primary antibodies; and AMCA-, fluorescein (FITC)- or Texas red--conjugated AffiniPure donkey anti--mouse IgG (H+L), anti--rabbit IgG (H+L), and anti--guinea pig IgG (H+L; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) as secondary antibodies. Specimens were viewed in a Zeiss Axiophot fluorescence microscope (Carl Zeiss, Oberkochen, Germany) or using the Bio-Rad MRC600 confocal scanning laser microscope (Richmond, CA). Photographs were taken using Ilford ASA 400 black and white film, and digital images were processed using the NIH Image 1.59 and Adobe Photoshop 4.01 software packages.

Expression of Recombinant Proteins in Bacteria
----------------------------------------------

His-tagged recombinant proteins encoded by pBN120 or pFS23 vector constructs were expressed in *Escherichia coli* BL21(DE3) and purified from inclusion bodies by solubilization in 6 M urea, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9 (binding buffer) containing 5 mM imidazole, followed by affinity binding to His-Bind metal chelation resin, according to the manufacturer\'s (Novagen Inc.) protocol. Bound proteins were eluted from affinity columns using 250 mM imidazole in binding buffer and stored frozen at −20°C. Samples were dialyzed against desired buffers before use to remove urea.

Gel Electrophoresis, Immunoblotting, and Preparation of 804G Cell Lysates
-------------------------------------------------------------------------

SDS-polyacrylamide gel electrophoresis (PAGE) was carried out under reducing conditions ([@B40]). Proteins on gels were visualized by staining with Servablue-G (Serva, Heidelberg, Germany). For immunoblotting, proteins were transferred to nitrocellulose sheets (Schleicher & Schuell, Dassel, Germany) for 4 h at 35 V in 25 mM Tris, 191 mM glycine, 0.01% SDS. After blocking with 3% BSA in TBS-T (TBS, containing 0.1% Tween-20), membranes were incubated with mAb 5B3 (1 h, room temperature), washed with TBS-T, and incubated with alkaline phosphatase-conjugated secondary goat anti--mouse antibody (Promega, Heidelberg, Germany). After washing, antibody binding was visualized with nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate in 100 mM Tris-HCl, pH 9.5, 100 mM NaCl, and 5 mM MgCl~2~.

Lysates of 804G cells were prepared by boiling cells in Laemmli\'s sample buffer (400 μl per confluent 10-cm plate) for 5 min.

Eu^3+^ Labeling of Recombinant Proteins and Microtiter Plate Overlay Assay
--------------------------------------------------------------------------

Recombinant mutant proteins were labeled with Eu^3+^ following the recommendations provided by the manufacturer (Wallac, Turku, Finland). 50--200 μg of recombinant integrin (β~4~-F~1,2~, β~4~-F~1,2~LF~3,4~C, β~4~-F~1,2~L, β~4~-LF~3,4~C, β~4~-F~3,4~C, β~4~-F~3,4~) and plectin (Ple-N~1~, Ple-R~3-6~T) mutant proteins were dialyzed against labeling buffer (50 mM sodium carbonate, pH 8.5) overnight at 4°C, and subsequently incubated with the labeling reagent (Eu^3+^-chelate of N^1^-(p-isothiocyanatobenzyl)-DTTA) at room temperature for ∼30 h. Unreacted labeling reagent was removed by gel filtration through a P6 column (Bio-Rad) equilibrated with 50 mM Tris-HCl, pH 7.5, 0.9% NaCl, 0.01% NaN~3~. Proteins were stored at 4°C until use. Microtiter plates were coated with recombinant proteins expressed in bacteria (100 μl of a 100 nM solution in 25 mM sodium borate buffer, pH 9.2) overnight at 4°C. Blocking was carried out with 4% BSA in TBS for 1 h and then binding with Eu^3+^-labeled proteins in 100 μl overlay buffer (TBS, pH 7.5, containing 1 mM EGTA, 2 mM MgCl~2~, 1 mM DTT, and 0.1% Tween 20) for 90 min at room temperature. After extensive washing with overlay buffer, the amount of bound proteins was determined by releasing complexed Eu^3+^ with enhancement solution and measuring the fluorescence with a Delfia time-resolved fluorometer (Wallac). The fluorescence values were converted to concentrations by comparison with an Eu^3+^ standard.

^125^I Labeling of Proteins and Blot Overlay Assay
--------------------------------------------------

The recombinant integrin β~4~ mutant protein β~4~-F~1,2~LF~3,4~C (∼0.8 mg) was dialyzed against 20 mM Tris-HCl, pH 7.5, and incubated with one Iodo-Bead (Pierce, Rockford, IL) and 0.5 mCi of Na^125^I (DuPont-NEN, Boston, MA) at room temperature for 15 min. Free iodine was removed by gel filtration using a Sephadex G-25 (Pharmacia Biotech Sverige, Uppsala, Sweden) column (0.9 × 14 cm) equilibrated with 20 mM Tris-HCl, pH 7.5, 1 mM DTT. Labeled proteins were stored at 4°C until use.

Purified recombinant integrin and plectin mutant proteins and lysates of induced bacterial cultures expressing plectin protein fragments were analyzed by SDS-10% PAGE. Proteins were blotted onto 0.2-μm nitrocellulose membranes (Schleicher & Schuell), overnight in 25 mM Tris, pH 8.8, and 192 mM glycine, at 25 V using a wet mini-blot apparatus (Bio-Rad). Membranes were incubated with 0.1% gelatin (Merck, Darmstadt, Germany) in PBS for 4 h at room temperature, and rinsed once with TSDT (20 mM Tris-HCl, pH 7.5, 250 mM NaCl, 1 mM DTT, 1% (vol/vol) Triton X-100). After incubation with 10 μg/ml of ^125^I- β~4~-F~1,2~LF~3,4~C in TSDT containing 0.5% BSA for 4 h and washing with TSDT, sheets were dried, sealed in plastic bags, and X-Omat film (Eastman Kodak, Rochester, NY) was exposed to them.

Immunoelectron Microscopy
-------------------------

Vascular perfusion of Wistar rats was performed with 4% paraformaldehyde in PBS, pH 7.4. Skin samples were immersed in fresh paraformaldehyde solution for 30 min and embedded in lowicryl-HM20 (Agar Scientific Ltd., Stansted, UK) as described in detail by [@B77]. Small pieces (∼1--2 mm^2^) of fixed rat skin were rinsed in PBS and dehydrated in a series of ethanol dilutions at −20°C and ethanol finally replaced by overnight infiltration of pure lowicryl. Samples were transferred into transparent tubes (Eppendorf, Hamburg, Germany) that were filled with freshly prepared lowicryl. Polymerization was complete after 24 h of exposure to UV light −28°C.

Lowicryl thin sections (60--80 nm) cut with an ultramicrotome (Ultracut S; Reichert, Vienna, Austria) were mounted on formvar-coated nickel slot grids. Postembedding immunolabeling was performed as previously described ([@B50]). Free aldehyde groups were reduced by incubating sections in 0.1 M glycine in PBS, three times for 5 min, and blocking was performed in normal goat serum (BioCell Res. Lab, Cardiff, UK) for 30 min. For immunolabeling, sections were incubated for 1 h at room temperature, or overnight at 4°C with one of the following domain-specific anti-plectin antibodies: *a*) anti-rod mAb 7A8 (Foisner et al., 1996), *b*) anti-amino terminus rabbit serum E1A raised against a synthetic peptide corresponding to a 12--amino acid residue-long sequence of human exon 1a, and *c*) anti-carboxy terminus mouse serum 135C raised against a recombinant rat plectin mutant protein corresponding to the carboxy-terminal repeat 4 domain (see [@B2]), or with non- immune serum or PBS as controls. Secondary labeling using 5 nm gold-conjugated goat-anti--mouse IgG and 1 nm gold-conjugated goat-anti-- rabbit IgG (BioCell Res. Lab) was performed for 1 h at room temperature. For visualization in the electron microscope, 1 nm or 5 nm colloidal gold particles were silver enhanced ([@B71]). Thin sections were counterstained with uranyl acetate and lead citrate and were viewed at 80 kV in a JEOL JEM-1210 electron microscope.

Results {#Results}
=======

Expression and Purification of Recombinant Forms of Integrin β~4~ and Plectin
-----------------------------------------------------------------------------

Localization of plectin at hemidesmosomes ([@B79]) and its function as an IF (cytokeratin)-binding protein make it a likely candidate to act as a linker between the cytokeratin filament network and the hemidesmosomal integrin α~6~β~4~. To test whether this proposed function of plectin involves its direct interaction with the uniquely long cytoplasmic tail of the β~4~ subunit of integrin α~6~β~4~, we generated a series of human integrin β~4~ and rat plectin truncation mutants (Fig. [1](#F1){ref-type="fig"}) for use in biochemical in vitro binding, as well as in vivo cell transfection assays.

The original design of our integrin β~4~ expression constructs was based on a report by [@B66], who showed that a 303--amino acid-long region of the cytoplasmic tail comprising the first of its two pairs of FNIII repeats and the following segment between the first and second pair was necessary for the recruitment of the integrin β~4~ subunit into hemidesmosomes. Integrin β~4~ subdomain-specific clones generated in the pET expression system are shown in Fig. [1](#F1){ref-type="fig"} *A.* Encoded proteins contained the cytoplasmic tail starting at the beginning of the first FNIII repeat (β~4~-F~1,2~LF~3,4~C), the 303--amino acid region described above (β~4~-F~1,2~L′), and the rest of the tail, starting in the third FNIII repeat, close to its beginning (β~4~-F~3,4~C′). β~4~-F~1,2~L and β~4~-F~3,4~C were similar to β~4~-F~1,2~L′ and β~4~-F~3,4~C′, respectively, except for excluding (β~4~-F~1,2~L) and including (β~4~-F~3,4~C) the third FNIII repeat in its entirety. β~4~-F~1,2~ corresponded to the first FNIII repeat pair, β~4~-F~3,4~ to the second; β~4~-LF~3,4~C lacked the first FNIII repeat pair. SDS-PAGE analysis of purified recombinant integrin β~4~ polypeptides expressed in *E. coli* confirmed that they were of the sizes predicted on the basis of the corresponding cDNA sequences, including the 2.6-kD his-tags (Fig. [2](#F2){ref-type="fig"}).

Plectin mutant proteins corresponding to different molecular regions of the amino- and carboxy-terminal globular domains of the molecule (Fig. [1](#F1){ref-type="fig"} *B*) were generated by subcloning rat plectin cDNAs into the pET expression system. Two amino-terminal protein fragments used covered the amino acid sequence encoded by exons 1--24 (Ple-N~1~) and exons 12--24 (PleN~2~). The other fragments covered, partly overlapping, the complete carboxy-terminal globular domain with its repeat structure. Ple-R~1~ started within the hinge region after the rod domain and included the first and part of the second repeat domain; Ple-R~3-6~T contained the rest of plectin\'s carboxy terminus. Two constructs, Ple-R~3~ and Ple-R~4-6~T, split construct Ple-R~3-6~T into two shorter ones, one corresponding to repeat 3 and parts of the flanking repeats 2 and 4, the other to the carboxy terminus starting in repeat 4. Ple-R~1-3~ was a combination of Ple-R~1~ and Ple-R~3~, ranging from plectin\'s hinge region into repeat 4. Ple-R~4,5~ contained repeat 4 and 5, Ple-R~4~ repeat 4 alone, and Ple-R~5~ repeat 5 alone. Ple-R~6~T contained a small portion of repeat 5, repeat 6 and the carboxy-terminal tail. Ple-R~6~ was equivalent to Ple-R~6~T but lacked the tail. Plectin mutant proteins expressed from these plasmids were all of the expected sizes, as determined by SDS-PAGE (Fig. [3](#F3){ref-type="fig"}, *A* and *B*). The double band observed for Ple-N~1~ was likely due to an additional translation initiation event at an in-frame ATG codon, resulting in a ∼15-kD shorter his-tagged protein version.

Different Subdomains of the Integrin β~4~ Cytoplasmic Tail Region Each Bind to Amino- and Carboxy-terminal Domains of Plectin
-----------------------------------------------------------------------------------------------------------------------------

To detect direct interaction between the candidate integrin β~4~ cytoplasmic tail region and various subdomains of plectin, we first used a qualitative blot overlay assay in which recombinant plectin fragments immobilized on nitrocellulose membranes were overlaid with ^125^I-labeled purified recombinant integrin β~4~-F~1,2~LF~3,4~C (Fig. [3](#F3){ref-type="fig"}, *C* and *D*). The plectin fragments used in these experiments covered the complete cDNA sequence (exons 1--32; [@B42]) with the exception of the predicted rod region (exon 31), a small part of the preceding amino-terminal globular domain (exons 25--30), and the three additional alternative start exons (1*a*, 1*b*, and 1*c*) identified recently ([@B12]). Among nearly a dozen recombinant plectin polypeptides tested, the one displaying highest binding activity to β~4~-F~1,2~LF~3,4~C was Ple-R~3-6~T, which contained most of plectin\'s carboxy-terminal globular domain. Plectin protein fragments corresponding to individual repeats (Ple-R~3~, Ple-R~4~, Ple-R~5~) showed no or hardly any binding activity, neither did fragments containing repeat 1 and part of the hinge region (Ple-R~1~), repeats 1--3 (Ple-R~1-3~), or repeats 4 and 5 combined (Ple-R~4,5~). Aside from Ple-R~3-6~T, the β~4~-F~1,2~LF~3,4~C polypeptide bound to all other plectin mutant proteins that contained repeat 6, such as Ple-R~4-6~T, Ple-R~6~T, and Ple-R~6~. β~4~-F~1,2~LF~3,4~C also reacted with the amino-terminal polypeptide fragments Ple-N~1~ and Ple-N~2~, suggesting that one or more additional interaction site(s) resided in this region of the plectin molecule.

To verify the blot overlay, and in order to assess plectin-integrin β~4~ interaction in a more quantitative way, we used an alternative, nonradioactive microtiter plate-binding assay involving Eu^3+^-labeled proteins, which had successfully been used in the molecular mapping of plectin\'s IF-binding site ([@B47]). The two plectin protein fragments representing amino- and carboxy-terminal domains and exhibiting highest binding efficiency in the blot overlay assay (Ple-N~1~ and Ple-R~3-6~T, Fig. [3](#F3){ref-type="fig"}) were used for this assay. β~4~-F~1,2~LF~3,4~C was coated onto 96-well microtiter plates and overlaid with increasing concentrations of the Eu^3+^-labeled plectin proteins (Fig. [4](#F4){ref-type="fig"} *A*). The amounts of proteins bound to the coated integrin fragment were determined by measuring released Eu^3+^ by time-resolved fluorometry ([@B62]). Non-specific binding to coated BSA was also determined and subtracted to give results for specific binding to β~4~-F~1,2~LF~3,4~C. Binding of both plectin proteins was similar up to 500 nM, where Ple-N~1~ reached saturation, contrary to Ple-R~3-6~T, which exhibited approximately twofold higher binding at 1,000 nM, consistent with the apparently stronger binding of ^125^I-β~4~-F~1,2~LF~3,4~C to this protein in the blot overlay assay (Fig. [3](#F3){ref-type="fig"}).

To map the plectin-binding site(s) in the integrin β~4~ cytoplasmic domain more precisely, Ple-R~3-6~T and Ple-N~1~ were separately coated and overlaid with samples of Eu^3+^-labeled integrin β~4~ mutant proteins (Fig. [5](#F5){ref-type="fig"}, *A* and *B*). Consistent with the qualitative blot overlay assay (Fig. [3](#F3){ref-type="fig"}), strongest binding was observed between β~4~-F~1,2~LF~3,4~C and the carboxy-terminal plectin fragment Ple-R~3-6~T (Fig. [5](#F5){ref-type="fig"} *A*, *first bar*). The same integrin β~4~ fragment bound to the amino-terminal plectin fragment Ple-N~1~ with just ∼30% lower efficiency (Fig. [5](#F5){ref-type="fig"} *B*, *first bar*). Among a panel of truncated versions of β~4~-F~1,2~LF~3,4~C tested, only those containing either the region between the second and third FNIII repeat (β~4~-F~1,2~L and β~4~-LF~3,4~C) and/or the carboxy-terminal tail region following the last FNIII repeat (β~4~-- LF~3,4~C and β~4~-F~3,4~C) showed significant binding to either one of the plectin fragments (Fig. [5](#F5){ref-type="fig"}, *A* and *B*). β~4~-F~1,2~ and β~4~-F~3,4~ hardly showed any detectable binding. These results suggested that at least two different plectin-binding domains were present in the cytoplasmic domain of the integrin β~4~ subunit, one between the two pairs of FNIII repeats, the other in the ultimate tail region trailing the second pair of FNIII repeats. Moreover, both binding domains apparently comprised interaction sites for amino- as well as carboxy-terminal domains of plectin.

To examine whether the different binding sites on integrin and plectin molecules have differential affinities for each other, integrin fragments β~4~-F~1,2~L and β~4~-F~3,4~C, each containing just one of the two putative plectin-binding regions, were coated onto microtiter plates and overlaid with either Eu^3+^-labeled Ple-N~1~ with or without a 10-fold molar excess of unlabeled Ple-R~3-6~T (Fig. [4](#F4){ref-type="fig"} *B*, *first column*) or, vice versa, with Eu^3+^-labeled Ple-R~3-6~T with or without a 10-fold molar excess of unlabeled Ple-N~1~ (Fig. [4](#F4){ref-type="fig"} *B*, *second column*). The results of these competition experiments, documented as the relative percentage of inhibition of binding in the presence of the competitor, are summarized in Fig. [4](#F4){ref-type="fig"} *B.* Ple-R~3-6~T was able to efficiently displace Ple-N~1~ from both, β~4~-F~1,2~L and β~4~-F~3,4~C, whereas reversely, Ple-N~1~ hardly could displace Ple-R~3-6~T from β~4~-F~1,2~L and inhibited its binding to β~4~-F~3,4~C by only ∼50%. The ability of the plectin mutant proteins to displace each other from the more carboxy-terminal integrin β~4~ plectin-binding domain (contained in β~4~-F~3,4~C) indicated that both exhibited affinities for the same binding site. Apparently, however, Ple-R~3-6~T bound to this site with higher affinity compared to Ple-N~1~, as indicated by its higher competition efficiency. This was consistent with the more efficient binding of β~4~-F~3,4~C to immobilized Ple-R~3-6~T, as compared to Ple-N~1~ in the microtiter plate assay (compare bars β~4~-F~3,4~C in Fig. [5](#F5){ref-type="fig"}, *A* and *B*). The inability of Ple-N~1~ to displace Ple-R~3-6~T from β~4~-F~1,2~L indicated also a significantly higher affinity of Ple-R~3-6~T, compared to Ple-N~1~, for the second, more amino-terminal plectin-binding site contained in this integrin β~4~ fragment (β~4~-F~1,2~L).

Integrin β~4~ Mutant Proteins Exhibit Self-association upon Immobilization
--------------------------------------------------------------------------

Competition experiments similar to those shown above (Fig. [4](#F4){ref-type="fig"} *B*) using immobilized plectin proteins and Eu^3+^- labeled integrin fragments in solution failed due to excessive self-interaction of integrin β~4~ mutant proteins upon immobilization, a situation which also prevented the determination of dissociation constants. The ability of integrin β~4~ cytoplasmic tail domains to self-associate potentially could have implications for certain functions of the protein, such as integrin clustering in hemidesmosomal complex formation and/or hemidesmosomal plaque-cytoskeleton anchorage. To obtain some information on possible molecular mechanisms and to identify the domain(s) mediating self-association, purified recombinant integrin β~4~ polypeptides representing various molecular domains were resolved by SDS-PAGE, blotted onto nitrocellulose, and overlaid with ^125^I-β~4~-F~1,2~LF~3,4~C (Fig. [6](#F6){ref-type="fig"}, *A* and *B*). β~4~-F~1,2~LF~3,4~C reacted strongly with itself, β~4~-F~1,2~L, and β~4~-F~3,4~C, but not detectably with β~4~-F~1,2~ or β~4~-F~3,4~. This indicated that the domains involved in the aggregation of integrin β~4~ were similar to those mediating integrin β~4~-plectin interactions. In solution, no such aggregation of integrin β~4~ proteins was found (data not shown). When β~4~-F~1,2~LF~3,4~C was coated and overlaid with Eu^3+^-β~4~-F~1,2~LF~3,4~C (Fig. [6](#F6){ref-type="fig"} *C*, *filled bars*) in either the standard overlay assay buffer (150 mM NaCl), buffer without NaCl, or buffer with increased NaCl concentration (500 mM), binding under high-salt conditions was fivefold increased over standard condition and about 10-fold reduced at low-ionic strength. Non-specific binding to BSA (Fig. [6](#F6){ref-type="fig"} *C*, *open bars*) was low and even decreased with increasing ionic strength. This experiment indicated that self-interaction of β~4~-F~1,2~LF~3,4~C was of hydrophobic nature. In a further experiment, increasing concentrations of Ple-R~3-6~T were added to a constant amount of Eu^3+^- β~4~-F~1,2~LF~3,4~C. As seen in Fig. [6](#F6){ref-type="fig"} *D*, plectin fragments decreased the extent of integrin β~4~ self-association in a concentration dependent manner. Presumably by binding to coated integrin β~4~ molecules, plectin fragments blocked integrin β~4~ self-association sites, which reside near or are even overlapping with the plectin-binding sites, as indicated by the blot overlay assay (Fig. [6](#F6){ref-type="fig"}, *A* and *B*).

Colocalization of Integrin β~4~ and Plectin Mutant Proteins Ectopically Expressed in Transfected PtK2 Cells
-----------------------------------------------------------------------------------------------------------

To test whether integrin β~4~ and plectin mutant proteins shown to interact in vitro would also interact when ectopically expressed in living cells, we transiently cotransfected PtK2 cells using various plectin and integrin β~4~ cDNA vector constructs driving the expression of c-*myc*--tagged and GFP-tagged proteins. Based on the in vitro binding data, we chose to express two plectin fragments, Ple-N~1~ ^GFP^, containing the amino-terminal integrin β~4~-binding site(s) identified above, and Ple-R~3-6~T*^myc^* (Ple-R~3-6~T^GFP^), the carboxy-terminal polypeptide exhibiting the strongest binding to integrin β~4~ among all the recombinant plectin mutant proteins tested. In a first series, PtK2 cells were cotransfected with plasmids encoding the carboxy-terminal plectin fragment and one of the plasmids encoding correspondingly tagged integrin β~4~ fragments β~4~-F~1,2~LF~3,4~C^GFP^, β~4~-F~1,2~LF~3,4~C*^myc^*, β~4~-F~1,2~L′*^myc^*, β~4~-F~1,2~ *^myc^*, and β~4~-F~3,4~C′*^myc^* (Fig. [7](#F7){ref-type="fig"}). Most transfected cells were double-transfected, expressing both the plectin and integrin proteins. A few cells bearing only one plasmid served as controls for single-transfected cells.

In cells coexpressing Ple-R~3-6~T*^myc^* and β~4~-F~1,2~LF~3,4~C^GFP^, the bulk of both ectopically expressed proteins showed codistribution and association with dense structures surrounding the nucleus; in addition, both were associated with small dot- or patch-like structures of unknown nature throughout the cytosol in superimposable patterns (Fig. [7](#F7){ref-type="fig"}, *A* and *B*). In rarely observed single-transfected cells expressing the plectin mutant protein alone, similar dot- and patch-like structures were not observed; such cells rather displayed filament association of mutant proteins (e.g., single-transfected cell in upper right-hand corner of Fig. [7](#F7){ref-type="fig"} *B*), or bundling and collapse of IFs, as previously reported ([@B47]). As revealed by triple-staining, the cytokeratin filaments of such cotransfected cells seemed to have completely collapsed onto the nuclei, rendering the remainder of the cytoplasmic space a cytokeratin-free zone, clearly outlined by adjacent cytokeratin-positive cells (Fig. [7](#F7){ref-type="fig"} *C*).

β~4~-F~1,2~L′*^myc^*, containing the first pair of FNIII repeats plus the region between the second and third FNIII repeat, colocalized with the carboxy-terminal plectin protein (Ple-R~3-6~T^GFP^) in dense aggregates as well as in more delicate filamentous structures (Fig. [7](#F7){ref-type="fig"}, *D* and *E*). These delicate structures were not seen in cells expressing Ple-R~3-6~T^GFP^ (see e.g., single-transfected cell in upper right-hand part of Fig. [7](#F7){ref-type="fig"} *E*) or β~4~-F~1,2~L′*^myc^* alone (see e.g., transfected cell in center of Fig. [10](#F10){ref-type="fig"} *I*), suggesting that their appearance was dependent on the coexpression of both the plectin and integrin β~4~ mutant proteins. This notion was supported by the observation that in double-transfected cells, expressing comparatively low levels of β~4~-F~1,2~L′*^myc^* compared to Ple-R~3-6~T^GFP^, delicate structures were hardly observed, but integrin-specific staining was confined to dense structures typical of collapsed filaments (see e.g., double-transfected cell in lower right-hand part of Fig. [7](#F7){ref-type="fig"}, *D--F*).

The expression product β~4~-F~3,4~C′*^myc^*, similar to β~4~-F~1,2~LF~3,4~C^GFP^ and β~4~-F~1,2~L′*^myc^*, colocalized with the coexpressed carboxy-terminal plectin polypeptide in dense perinuclear structures (Fig. [7](#F7){ref-type="fig"}, *G* and *H*), different from the dispersed patches observed when this integrin construct was expressed alone (Fig. [7](#F7){ref-type="fig"} *G*). In contrast, β~4~-F~1,2~ *^myc^*, which lacked plectin-binding activity in vitro, was diffusely localized in small dots throughout the cell, regardless of whether or not the cell was cotransfected with the plectin construct (Fig. [7](#F7){ref-type="fig"}, *I* and *J*). As expected, plectin staining was independent of integrin β~4~ localization and its characteristics were similar to those of plectin only expression (Fig. [7](#F7){ref-type="fig"} *J*).

The plasmid encoding the amino-terminal plectin protein Ple-N~1~ ^GFP^ was used in a second set of similar cotransfection experiments using PtK2 cells (Fig. [8](#F8){ref-type="fig"}). Cells, cotransfected with the plasmid encoding β~4~-F~1,2~LF~3,4~C*^myc^*, displayed colocalization of both ectopically expressed polypeptides in brightly stained patches (Fig. [8](#F8){ref-type="fig"}, *A* and *B*). Colocalization was also observed with β~4~-F~1,2~L′*^myc^* (Fig. [8](#F8){ref-type="fig"}, *C* and *D*), but the dots and patches double-stained in this case were smaller and distributed more uniformly throughout the cell as compared to the structures formed with β~4~-F~1,2~LF~3,4~C*^myc^*. A similar confinement of both mutant proteins within distinct dots and patches was also found in cells coexpressing β~4~-F~3,4~C′*^myc^* and Ple-N~1~ ^GFP^ (Fig. [8](#F8){ref-type="fig"}, *E* and *F*). In a single-transfected cell the weakly expressed β~4~-F~3,4~C′*^myc^* was found diffusely distributed within the nuclear compartment and in form of dots and patches in the cytosol (Fig. [8](#F8){ref-type="fig"} *E*). In contrast, β~4~-F~1,2~ *^myc^*, which lacks both putative plectin-binding sites, remained diffusely distributed throughout the cell (Fig. [8](#F8){ref-type="fig"} *G*), without showing the dotty staining pattern of the plectin protein (Fig. [8](#F8){ref-type="fig"} *H*).

Ultrastructural Localization of Plectin at Hemidesmosomes Using Domain-specific Antibodies
------------------------------------------------------------------------------------------

To examine whether plectin molecules found at hemidesmosomal junctions in tissues are located within distances short enough to enable their interaction with plasma membrane-anchored integrin β~4~, immunogold electron microscopy of acrylic resin-embedded rat skin samples was performed. Embedding in lowicryl HM20 was found to provide excellent conditions for thin sectioning of rat skin specimens (below 100 nm), and enabled adequate hemidesmosomal fine structure resolution, comparable to other protocols ([@B53]; [@B59]). Considering that individual plectin molecules have been visualized as structures 200 nm in length, and probably can extend over even longer distances ([@B13]; Foisner et al., 1995; [@B73]), we used antibodies raised against epitopes of plectin residing in three different domains of the molecule, the amino terminus (serum E1A), the rod (mAb 7A8), and the carboxy terminus (serum 135C). All three of these domain-specific immunoreagents were found to be reactive with epitopes at the periphery as well as in the cytoplasmic interior of keratinocytes. Labeling was most intense near basolateral plasma membrane domains, in particular at the locations of hemidesmosomes (Fig. [9](#F9){ref-type="fig"}, *A--C*) and desmosomes (not shown; see also [@B11]), and along cytoplasmic cytokeratin filament bundles. In the area of hemidesmosomes, label was found at the plaque, at the inner plate, and in association with cytokeratin filaments (Fig. [9](#F9){ref-type="fig"}, *A--C*).

None of the domain-specific anti-plectin antibodies showed noticeable preference in labeling of any hemidesmosomal substructures. Furthermore, based on the resolution of the indirect immunogold labeling used (20--30 nm), it was unlikely that plectin molecules in hemidesmosomal basolateral regions were oriented in the same way and arranged in equidistal positions. These data were consistent with a model, in which randomly oriented plectin molecules can span over the entire distance between plasma membrane-associated hemidesmosomal integrin receptor complexes and hemidesmosomal inner plate-anchored cytokeratin filament bundles (Fig. [9](#F9){ref-type="fig"} *D*).

Overexpression of Integrin β~4~ Cytoplasmic Tail Domain Leads to Intermediate Filament Collapse in PtK2 and 804G Cells
----------------------------------------------------------------------------------------------------------------------

To assess whether the cytoplasmic domains of integrin β~4~ involved in plectin interaction would have any influence on cytoskeleton integrity, specifically IF-anchorage at plasma membrane sites, we monitored vimentin and cytokeratin network arrays in transfected PtK2 cells using double and triple immunofluorescence microscopy. Upon expression of β~4~-F~1,2~LF~3,4~C^GFP^, cytokeratin arrays were found aggregated and partially codistributed with the integrin mutant protein in perinuclear areas (Fig. [10](#F10){ref-type="fig"}, *A* and *B*). In fact, this phenotype was very similar to that observed after cotransfection of PtK2 cells using integrin β~4~ and plectin vector constructs in combination (compare to Fig. [7](#F7){ref-type="fig"} *C*). Triple immunofluorescence microscopy revealed that both the vimentin and cytokeratin network arrays had undergone collapse in such cells (Fig. [10](#F10){ref-type="fig"}, *C--E*). Similar observations were made when PtK2 cells were transfected using the integrin β~4~ tail construct β~4~-F~3,4~C′*^myc^* (Fig. [7](#F7){ref-type="fig"}, *F--H*). In contrast, ectopic expression of β~4~-F~1,2~L′*^myc^*, which lacked the carboxy-terminal part contained in β~4~-F~1,2~LF~3,4~C^GFP/*myc*^ and β~4~-F~3,4~C′*^myc^*, did not lead to such a drastic collapse of IF networks (Fig. [10](#F10){ref-type="fig"}, *I--K*). Instead, a partial association of the expressed protein with the IF network, specifically with a dense perinuclear ring-like structure, was observed. This ring-like structure, which was also present in untransfected cells, appeared more pronounced in transfected cells; and cytoplasmic IFs, especially the cytokeratin network, appeared diminished (Fig. [10](#F10){ref-type="fig"}, *J* and *K*). Because both, β~4~-F~1,2~LF~3,4~C^GFP^ and β~4~-F~3,4~C′*^myc^*, but not β~4~-F~1,2~L′*^myc^* contained the carboxy-terminal region shown to exhibit plectin-binding activity in vitro, we conclude that this tail domain was sufficient to cause the collapse of both IF systems in PtK2 cells.

To confirm these studies, similar transfection experiments were carried out using rat bladder carcinoma 804G cells, a cell line that forms hemidesmosome-like structures when grown on uncoated glass coverslips or plastic tissue culture dishes ([@B54]). Similar to PtK2 cells, transfection of 804G cells with the plasmid encoding β~4~-F~1,2~LF~3,4~C*^myc^* led to bundling of cytokeratin filaments and their partial collapse in perinuclear areas; the ectopically expressed protein was again visualized within dense, patchy structures, and partly colocalized with the collapsed cytokeratin filaments (Fig. [11](#F11){ref-type="fig"}, *A* and *B*). Complete network collapse was observed in cells expressing β~4~-F~3,4~C′*^myc^*; in this case, the mutant protein was found colocalized with cytokeratins in dense, ring-like structures around the nucleus (Fig. [11](#F11){ref-type="fig"}, *C* and *D*). In cells transfected with plasmids encoding β~4~-F~1,2~L′*^myc^* (Fig. [11](#F11){ref-type="fig"}, *E* and *F*), the expressed protein was found more or less diffusely distributed throughout the cell, with an apparent association with dense, perinuclear cytokeratin structures. β~4~-F~1,2~ *^myc^* (Fig. [11](#F11){ref-type="fig"}, *G* and *H*) was diffusely distributed throughout the cytoplasm with no apparent effect on the cytokeratin network array. Thus, the phenotypes of transfected 804G cells were fully consistent with those of PtK2 cells.

Expression of Integrin β~4~ Cytoplasmic Tail Domain Prevents Hemidesmosome Association of Plectin in 804G Cells
---------------------------------------------------------------------------------------------------------------

Because some of the integrin β~4~ mutant proteins overexpressed in 804G and PtK2 cells had a dramatic impact on cytoplasmic IF network organization, and were able to bind to recombinant plectin fragments, we wanted to test whether overexpression of these polypeptides in such cells would also affect the distribution of endogenous cytoplasmic plectin structures. As revealed by double immunofluorescence microscopy of untransfected 804G cells using antiserum raised against the 17 most carboxy-terminal amino acids of the integrin β~4~ subunit ([@B21]), and mAb 5B3 reacting with plectin\'s central rod domain ([@B15]), plectin and integrin β~4~ showed colocalization in a pattern previously described as Swiss cheese-like ([@B34]) and characteristic of the hemidesmosome-like structures abundantly expressed by these cells (Fig. [12](#F12){ref-type="fig"}, *A* and *B*). Both antigens were predominantly located at the basal membrane of these cells, as confirmed by confocal laser scanning microscopy of vertical sections (Fig. [12](#F12){ref-type="fig"}, *A* and *B*, *insets*). This hemidesmosome-associated 5B3-immunoreactive plectin species represented the major form of the protein in 804G cells, as confirmed by Western blot analysis of 804G cell lysates. Using mAb5B3, a single major immunoreactive band of apparent high molecular weight (\>300,000) comigrating with plectin isolated from rat glioma C6 cells, the original source of the immunogen ([@B15]), was observed (Fig. [12](#F12){ref-type="fig"} *C*).

Upon transient expression of integrin β~4~ mutant proteins containing one or both of the putative plectin-binding regions, the distribution of endogenous plectin was significantly altered. In cells expressing mutant proteins that caused the collapse of cytokeratin network arrays, such as β~4~-F~1,2~LF~3,4~C*^myc^* and β~4~-F~3,4~C′*^myc^*, the punctuate plectin-staining pattern typical of hemidesmosomes was greatly diminished (Fig. [13](#F13){ref-type="fig"}, *A--D*). Instead, remaining plectin-specific staining appeared rather diffuse, with the possible exception of peripheral areas, where a few positively stained filamentous structures became apparent. Similarly, upon expression of β~4~-F~1,2~L′*^myc^*, the punctuate plectin-specific signal associated with hemidesmosomes was hardly detectable anymore (Fig. [13](#F13){ref-type="fig"} *F*). In fact, such cells seemed almost completely depleted of plectin. Expression of the integrin mutant protein corresponding to the first and second FNIII repeat (β~4~-F~1,2~ *^myc^*), which lacked a plectin-binding site and was diffusely distributed over the entire cell (Fig. [13](#F13){ref-type="fig"} *G*), left the punctuate plectin-staining pattern intact, indicating no alteration of plectin\'s localization at hemidesmosomes (Fig. [13](#F13){ref-type="fig"} *H*).

Discussion {#Discussion}
==========

The uniquely long cytoplasmic domain of the β~4~ subunit protein has been implicated in connecting the α~6~β~4~ integrin complex with cytoskeletal elements ([@B58]; [@B66]; [@B4]; [@B24]), likely via cytoplasmic components of hemidesmosomes that are capable of cytokeratin filament interaction. Plectin, as a versatile IF-binding and cytoskeletal linker protein that has been shown to occur at hemidesmosomes ([@B79]), was a strong candidate for mediating this interaction. In this report, we demonstrate a direct interaction between recombinant integrin β~4~ and plectin proteins using two independent in vitro binding assays and in vivo cotransfection experiments. Furthermore, we show that integrin β~4~ polypeptides containing a ∼250--amino acid-long carboxy-terminal sequence led to bundling and collapse of IF network arrays, possibly through interference with IF-membrane association, and affected the subcellular distribution of cellular plectin when ectopically expressed in a nonmembrane- associated state.

The integrin β~4~ cDNA constructs used in our study were designed such that they encoded the entire or truncated forms of the cytoplasmic tail domain starting with the first FNIII repeat. One of the objectives pursued in this way was to express, in cells, integrin β~4~ proteins that would not associate with the cell membrane but would remain soluble in the cytoplasm. In this form they would also resemble fragments of ∼70 kD resulting from proteolytic processing of cellular integrin β~4~, which has been investigated by [@B21]. As suggested by these authors, formation of these cytoplasmic, nonmembrane-attached β~4~ subunit fragments is likely to be functional and related to the remodeling of adhesive and cytoskeletal structures occurring in the skin when basal cells detach from the basement membrane at the onset of differentiation and movement to upper cell layers. In addition, we used plectin cDNA constructs that encoded parts of the amino- and carboxy-terminal globular domains, both of which have been shown to harbor functional sites, including a highly conserved amino-terminal actin-binding domain ([@B12]), and an IF-binding site within the carboxy-terminal repeat 5 domain ([@B47]).

We used affinity blotting, a commonly used method to detect direct interaction between molecules (for review see [@B49]), to demonstrate that plectin\'s carboxy-terminal repeat 6 domain is essential for binding to integrin β~4~. However, our data also indicated that other synergy sites contained in domains flanking repeat 6 facilitated binding, because larger fragments extending beyond repeat 6 showed stronger binding. Additional integrin β~4~-binding sites were found to be contained in the amino-terminal globular domain of plectin. These binding data were confirmed by a microtiter plate-binding assay using Eu^3+^-labeled proteins as soluble reagents. Moreover, at least two separate plectin-binding sites were found within the cytoplasmic domain of integrin β~4~, one within the 142--amino acid-long segment connecting the two pairs of FNIII repeats, the other within the ultimate tail domain of the molecule. Both showed affinities for the same amino- as well as carboxy-terminal parts of plectin, as indicated by competition assays. Cotransfection of PtK2 cells with plasmids encoding mutant integrin β~4~ and plectin polypeptides fully confirmed these in vitro results. In fact, the in vivo expression experiments can be considered essentially as a third binding assay, as interacting proteins were found codistributed in patterns distinctly different from those observed when only one of the mutant proteins was ectopically expressed in cells. Thus, in vitro and in vivo binding data both suggested that plectin-integrin β~4~ binding was complex, involving multiple interfaces of the proteins.

Sequences in the linker segment between the first and second FNIII repeat pair have been shown to be important for integrin β~4~ functions. [@B66] showed that a 303--amino acid-long region of the integrin β~4~ cytoplasmic tail domain starting with the first FNIII repeat was essential for association of the molecule with hemidesmosomes. The necessary sequences were later narrowed down to the second FNIII repeat and a stretch of 27 amino acids (1,329--1,355) of the linker segment ([@B45]). Furthermore, the regions responsible for hemidesmosome localization have also been implicated in regulating the distribution of HD1 upon overexpression in COS-7 cells ([@B45]). We show here for the first time that this linker segment apparently is also involved in integrin β~4~ self-interaction, aside from harboring one of the two plectin-binding regions identified in our study. Self-association of integrin β~4~ may allow for efficient, cooperative clustering of these molecules in the dense hemidesmosomal plaque. Interestingly, our competition binding experiments indicated that plectin fragments containing integrin-binding domains attenuated the self-association of integrin β~4~, suggesting a potential role of plectin in the regulation of this process. Whether integrin β~4~ and plectin molecules compete for binding sites located close enough to sterically hinder binding of the second ligand, or even compete for the same sites, remains to be established. Further functional diversity of the segment between the FNIII repeat pairs is further underlined by the complexity of the gene locus encoding it and the identification of variants generated by alternative splicing of exons 33 and 35 within this locus ([@B30]; [@B74]; [@B52]).

The integrin β~4~ tail segment following the second FNIII repeat pair apparently is another subdomain of integrin β~4~ involved in multiple functions. Similar to the segment between the first and second FNIII repeat pair, this region exhibited binding to the integrin β~4~ cytoplasmic domain itself, as well as plectin amino- and carboxy-terminal domains. In addition, fragments containing this segment were highly efficient in causing IF collapse upon overexpression in PtK2 and 804G cells. In none of the previous studies we are aware of were specific functions assigned to, or binding partners identified in this region of integrin β~4~. A possible reason for this may be the predominant usage of carboxy terminally truncated mutants of integrin β~4~, because functions of carboxy-terminal fragments may easily escape detection, particularly when they are partially redundant, such as in the case of integrin β~4~ self-interaction and binding to plectin.

The role of the FNIII repeats remains unclear. We have shown that the pairs of FNIII repeats present in the integrin β~4~ cytoplasmic tail do not interact directly with plectin. However, they may be important for providing a structural framework allowing other parts to function efficiently. Supporting this point, integrin β~4~-LF~3,4~C, which lacked the first FNIII repeat pair, showed reduced binding to plectin in vitro, compared to β~4~-F~1,2~LF~3,4~C. Alternatively, some of the repeats may directly take part in interaction with other components. In a recent study, the second FNIII repeat, in addition to parts of the linker segment between the two FNIII pairs, has been shown to be crucial for the targeting of recombinant integrin β~4~ mutants to hemidesmosomes and interaction with HD1 ([@B45]). Additionally, the FNIII repeats may also interact with elements of the signal transduction pathway(s) coupled to the α~6~β~4~ integrin ([@B43]).

In view of plectin\'s putative major role as a cytoskeletal linker and stabilizer molecule, one may expect that overexpression of a plectin-binding protein would exert some influence on plectin\'s cellular function(s) by competitive binding to plectin, possibly leading to blocking of, or interference with, some of the endogenous binding partners. This could result in dominant negative phenotypes, detectable in structures, the integrity of which is dependent on a particular plectin linkage function. In line with this notion, we found that overexpression of integrin β~4~ mutant polypeptides containing the second putative plectin-binding site located in the carboxy-terminal region (β~4~-F~1,2~LF~3,4~C*^myc^* ^/GFP^ and β~4~-F~3,4~C′*^myc^*) led to the complete collapse of vimentin and cytokeratin IF network systems in PtK2 and 804G cells. Because ectopically expressed β~4~-F~1,2~L′*^myc^*, which lacked this domain but still contained the more amino-terminal plectin-binding region, was much less effective, we conclude the carboxy-terminal tail segment of integrin β~4~, starting with the second FNIII repeat pair, is the dominant effector of this phenotype.

Niessen et al. ([@B45],*b*), who expressed membrane- associated integrin β~4~ molecules comprising the complete or parts of the cytoplasmic domain in COS-7 cells, contrary to our results, did not observe any cytoskeletal phenotype. There are a number of possible explanations for this difference. First, integrin mutant effector molecules need to be freely available (soluble) in the cytoplasm, because in a membrane-bound state they may be too distant from target plectin molecules. Second, the membrane-bound mutant proteins do in fact interact with plectin, but keep the IF network bound to the membrane, and thus, in a noncollapsed state. Third, though unlikely, COS-7 cells are phenotypically different from PtK2 and 804G cells. We favor the second explanation, which allows for a mechanism, in which cytosolic integrin β~4~ mutant proteins are in competition with their wild-type counterparts as well as other membrane-associated plectin-binding proteins, such as fodrin and α-spectrin ([@B28]). Prohibiting the attachment of IFs to the plasma membrane, this situation could eventually lead to a collapse of IFs toward the perinuclear region. This interpretation is supported by the observation that endogenous 804G cell plectin, the localization of which was restricted largely to basal hemidesmosome-like structures in untransfected cells, upon expression of the plectin-binding sites containing integrin β~4~ polypeptides (β~4~-F~1,2~LF~3,4~C*^myc^* and β~4~-F~3,4~C*^myc^*), showed a diffuse cytoplasmic localization. Downregulation of plectin expression, in addition to relocalization of the membrane-bound species, may have been responsible for the even more drastic phenotype in the case of β~4~-F~1,2~L*^myc^*, where endogenous plectin was hardly detectable any more (Fig. [13](#F13){ref-type="fig"} *F*). Similar phenomena involving IF collapse and/or relocalization of endogenous proteins have been observed after overexpression of wild-type or mutant versions of IF-associated proteins, including desmoplakin ([@B69]), plectin ([@B81]), and various IF subunit proteins themselves ([@B1]; for review also see [@B17]), and after microinjection of antibodies to a whole range of antigens, including IF-associated and other proteins, into cultured cells.

In all, the plectin phenotypes of cells, transfected with various truncated versions of the integrin β~4~ cytoplasmic domain, were fully compatible with the data-characterizing plectin as a direct interaction partner of hemidesmosomal integrin β~4~. Notably, mutant integrin β~4~ proteins leading to filament collapse also caused relocalization of plectin from hemidesmosomes in 804G cells, suggesting that the collapse may in fact be indirect, mediated through plectin. Furthermore, overexpression of integrin β~4~ polypeptides, containing the different plectin-binding sites identified individually, resulted in distinct phenotypes, consistent in two different cell lines. Hence, our findings are in favor of a hypothesis put forward by [@B21], that proteolytic processing of the β~4~ subunit of the basement membrane receptor integrin α~6~β~4~, resulting in a number of defined cleavage products is related to the remodeling of adhesive and cytoskeletal structures. Additional support for this proposal is provided by our unpublished observation that transfected 804G cells overexpressing integrin β~4~ polypeptides, representing such proteolytic fragments, frequently had a rounder morphology, were apparently in the process of detachment from the substrate, and could be found in a second cell layer in dense cultures.

Recent studies with patients suffering from EBS-MD linked this disease to defects in plectin expression ([@B44]). Furthermore, in plectin (−/−) mice with a similar phenotype, the hemidesmosomes in epidermal keratinocytes were found to be ultrastructurally intact and numerous filaments emanated from their cytoplasmic face, indicating that their ability to serve as filament anchorage sites was at least to a certain extent preserved ([@B2]). In contrast, BPAG1-deficient mice clearly lacked the hemidesmosomal inner plate, and consequently did not show keratin filament anchorage at the basal cell surface membrane ([@B26]). Thus, plectin is probably dispensable for the formation of hemidesmosomes. However, there is mounting evidence that this protein is important for the integrity and stability of hemidesmosomal junctions. First, the expression of integrin β~4~ was found to be significantly reduced in plectin-deficient mice ([@B2]), as has been reported for mice deficient in another binding partner of integrin β~4~, the integrin subunit α~6~ ([@B19]), and second, hemidesmosome structures of plectin-deficient mice seemed to be fragile, as a peculiar, bipartite distribution of BPAG1 was observed in a discontinuous pattern both at the bottom and the top of blisters in the skin of these animals; this suggested a mechanism of cell breakage in which rupture can occur irregularly on both sides (apical and basal) of the hemidesmosome inner plate, or within the plate itself.

Based on *a*) the results reported in this study, in particular, plectin\'s ability to interact via carboxy- as well as amino-terminal domains with the cytoplasmic tail of integrin β~4~ and its close association with hemidesmosomes as demonstrated by immunoelectron microscopy, *b*) our previous identification of a highly conserved IF (cytokeratin)- binding site in the carboxy-terminal globular domain of plectin molecules ([@B47]), and *c*) the skin phenotype observed in plectin (−/−) mice ([@B2]) and EBS-MD patients, we propose that plectin molecules act as stabilizers of hemidesmosomes according to the schematic model depicted in Fig. [9](#F9){ref-type="fig"} *D.* In this model, plectin molecules form clamps bridging hemidesmosomal components with the IF networks by directly interacting with both plasma membrane-associated integrin β~4~ and cytoplasmic cytokeratin filaments. Binding sites for integrin β~4~ in both the amino- and carboxy-terminal globular domains of plectin would allow parallel as well as antiparallel plectin oligomeres to form interactions on both ends (see [@B13], and [@B80], for discussions of putative dimeric and tetrameric plectin molecule structures). Multiple mutual binding sites on both integrin β~4~ and plectin may afford stronger resistance towards the great mechanical stress hemidesmosomes must be exposed to, yet retain the flexibility needed for such dynamic structures as they have shown to be ([@B37]; [@B55]).

In conclusion, we have identified the β~4~ subunit of the hemidesmosome-associated laminin receptor complex integrin α~6~β~4~ as a novel interaction partner of plectin and we have mapped interacting domains on both molecules. In a more global picture our results lend further support to the proposed role of plectin as a versatile and essential cytoskeletal linker protein that may contribute to the cytoarchitectural organization and mechanical reinforcement of cells by cross-linking IFs, interlinking them with other cytoskeletal network systems, and participating in their anchorage at the plasma membrane at specialized structures.
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![(*A*) Schematic representation of human integrin β4 mutant proteins and summary of their plectin-binding phenotype in vitro and in vivo. Drawing on top shows major structural motifs contained in the integrin β~4~ subunit. *EC* and *IC*, extracellular part (not fully shown) and intracellular part, respectively; *TM*, transmembrane domain; *F~1~--F~4~*, fibronectin type III-like repeat domains; *L*, linking segment between the first and second repeat pair; *C*, carboxy-terminal domain after the second repeat pair. Details about generation and description of cDNA constructs and expressed proteins are given in the text. Table on right hand side indicates whether (+) or not (−) a given integrin mutant protein bound to the carboxy- (*C* = Ple-R~3-6~T) or amino-terminal (*N* = Ple-N~1~) plectin mutant protein in the Eu^3+^-overlay (*in vitro*) or transfection assays (*in vivo*). (*B*) Schematic representation of rat plectin mutant proteins and summary of their in vitro binding ability to the β~4~-F~1,2~LF~3,4~C polypeptide. Drawings include the major molecular domains of plectin: *ABD*, actin-binding domain; *Rod*, plectin rod domain; *IFBD*, IF binding domain; *R~1~--R~6~*, carboxy-terminal repeats domains 1--6; *T*, carboxy-terminal tail after repeat 6. Expression plasmids were generated as outlined in the text. Summary table at right shows semiquantitative assessment (strongest reaction: ++++, no binding: −) of the in vitro binding data shown in Fig. [3](#F3){ref-type="fig"} (blot overlay of various plectin mutant proteins with the integrin β~4~ polypeptide β~4~-F~1,2~LF~3,4~C).](JCB15097.f1){#F1}

![Blot overlay of recombinant plectin proteins with ^125^I-labeled β~4~-F~1,2~LF~3,4~C. Purified his-tagged recombinant plectin proteins Ple-N~1~, Ple-N~2~, Ple-R~1~, Ple-R~3-6~T, Ple-R~4,5~, Ple-R~4~, Ple-R~5~, and Ple-R~6~ (*A* and *C*), and whole lysates of induced bacterial cultures (*B* and *D*) expressing his-tagged plectin recombinant proteins Ple-R~1-3~, Ple-R~3~, Ple-R~4-6~T, Ple-R~6~T, and a non-induced bacterial culture, were subjected to SDS 10% PAGE in duplicate. Proteins on one set of gels were stained with Servablue-G (*A* and *B*), those on the other set were blotted onto nitrocellulose membranes, overlaid with ^125^I-β~4~-F~1,2~LF~3,4~C (his-tagged), and bound integrin β~4~ protein detected by autoradiography (*C* and *D*). Size markers of 200, 97, 68, 43, and 29 kD are indicated.](JCB15097.f3){#F3}

![SDS-PAGE of integrin β~4~ mutant proteins expressed in bacteria. His-tagged recombinant proteins were purified from bacterial inclusion bodies as described in the text and analyzed on a 12% polyacrylamide gel. Proteins were visualized by staining the gel with Servablue-G. The predicted masses of recombinant proteins were: 71.4 kD (*β~4~-F~1,2~LF~3,4~C*), 39.4 kD (*β~4~-F~1,2~L*), 24.0 kD (*β~4~-F~1,2~*), 50.4 kD (*β~4~-LF~3,4~C*), 35.0 kD (*β~4~-F~3,4~C*), 25.4 kD (*β~4~-F~3,4~*), 42.6 kD (*β~4~-F~1,2~L′*), and 31.8 kD (*β~4~-F~3,4~C′*). Molecular weight markers are indicated (×10^−3^).](JCB15097.f2){#F2}

![Concentration dependent (*A*) and competitive binding (*B*) of Eu^3+^- labeled recombinant plectin polypeptides to immobilized recombinant integrin β~4~ cytoplasmic tail polypeptide. (*A*) β~4~-F~1,2~LF~3,4~C (100 nM) was coated onto microtiter plates and overlaid with increasing concentrations (10--1,000 nM) of Eu^3+^-labeled Ple-N~1~ (•) or Ple-R~3-6~T (○). Data shown have been corrected for nonspecific binding to BSA. Note, for concentrations up to 500 nM error bars do not extend outside of symbols. (*B*) Table summarizing competition experiments: β~4~-F~1,2~L or β~4~-F~3,4~C were coated onto microtiter plates (100 nM) and overlaid with either Eu^3+^-labeled Ple-N~1~ (100 nM) in the absence and presence of a 10-fold molar excess (1 μM) of unlabeled Ple-R~3-6~T (column *2*) or Eu^3+^-labeled Ple-R~3-6~T (100 nM) in the absence and presence of a 10-fold molar excess (1 μM) of unlabeled Ple-N~1~ (column *3*). Extent of inhibition of binding was calculated as 100 − 100 × (binding with competitor/binding without competitor). Amounts of plectin proteins bound were determined by measuring released Eu^3+^ by time-resolved fluorometry after addition of enhancement solution as described in the text. All data (*A* and *B*) are presented as the mean ± SD of duplicate determinations.](JCB15097.f4){#F4}

![Binding of Eu^3+^- labeled recombinant integrin β~4~ polypeptides to plectin carboxy- (*A*) and amino-terminal (*B*) protein domains immobilized on microtiter plates. 100 nM purified his-tagged recombinant plectin mutant proteins Ple-R~3-6~T and Ple-N~1~ were coated onto microtiter plates and separately overlaid with Eu^3+^- labeled integrin β~4~ proteins β~4~-F~1,2~LF~3,4~C, β~4~-F~1,2~L, β~4~-F~1,2~, β~4~-LF~3,4~C, β~4~-F~3,4~C, and β~4~-F~3,4~ (2.5 μM each). Amounts of bound integrin β~4~ proteins were determined as described in Fig. [4](#F4){ref-type="fig"}. Data are presented as the mean ± SD of duplicate determinations.](JCB15097.f5){#F5}

###### 

Self-association of recombinant integrin β~4~ cytoplasmic tail fragments. (*A* and *B*) Blot overlay: purified his-tagged recombinant integrin β~4~ proteins β~4~-F~1,2~LF~3,4~C, β~4~-F~1,2~L, β~4~-F~1,2~, β~4~-F~3,4~C, and β~4~-F~3,4~ were subjected to SDS 10% PAGE in duplicate. Proteins on one gel were stained with Servablue-G (*A*), those on the other were blotted onto nitrocellulose membrane, overlaid with ^125^I-β~4~-F~1,2~LF~3,4~C, and bound integrin β~4~ protein detected by autoradiography (*B*). Size markers of 97, 68, 43, 29, 18.4, and 14.3 kD are indicated. (*C*) Ionic strength dependence: β~4~-F~1,2~LF~3,4~C (*filled bars*) and BSA (*open bars*) were coated (both at 100 nM) and overlaid with Eu^3+^-labeled β~4~-F~1,2~LF~3,4~C (50 nM) in solutions of different ionic strengths (0, 150, and 500 mM NaCl). Scale is normalized for extent of binding under standard conditions (150 nM NaCl). Data are presented as the mean ± SD of duplicate determinations. (*D*) Competition experiment: β~4~-F~1,2~LF~3,4~C was coated (100 nM) and overlaid with 100 nM Eu^3+^-labeled β~4~-F~1,2~LF~3,4~C and different concentrations (0--2 μM) of Ple-R~3-6~T. Scale is normalized for extent of binding in the absence (0 μM) of Ple-R~3-6~T (100%). Data are presented as the mean ± SD of duplicate determinations.
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![Coexpression of the carboxy-terminal plectin protein Ple-R~3-6~T and various integrin β~4~ mutant proteins in PtK2 cells. Cells plated on glass coverslips were cotransfected with a plectin construct encoding Ple-R~3-6~T (with either c-*myc*-tag or GFP linked to the carboxy terminus) and one of the integrin β~4~ constructs encoding β~4~-F~1,2~LF~3,4~C^GFP^ (*A--C*), β~4~-F~1,2~L′*^myc^* (*D--F*), β~4~-F~3,4~C′*^myc^* (*G* and *H*), or β~4~-F~1,2~ *^myc^* (*I* and *J*). After ∼48 h, cells were fixed and double- or triple-stained. (*A*, *D*, *G*, and *I*) Ectopically expressed integrin β~4~ proteins, tagged with GFP (*A*; FITC optics) or c-*myc* (*D*, *G*, and *I*; Texas red optics). (*B*, *E*, *H*, and *J*) Ectopically expressed plectin protein tagged with c-*myc* (*B*; Texas red optics) or GFP (*E*, *H*, and *J*; FITC optics). (*C* and *F*), cytokeratins and vimentin, respectively, visualized by UV optics (AMCA). Note colocalization of β~4~-F~1,2~LF~3,4~C^GFP/*myc*^, β~4~-F~1,2~L′*^myc^*, and β~4~-F~3,4~C′*^myc^*, but not β~4~-F~1,2~ *^myc^*, with the carboxy-terminal plectin polypeptide (Ple-R~3-6~T^GPF/*myc*^). Bar, 15 μm.](JCB15097.f7){#F7}

![Collapse of IF network arrays in PtK2 cells ectopically expressing different integrin β~4~ cytoplasmic tail domain fragments. Cells plated on glass coverslips were transfected with cDNA constructs encoding mutant integrin β~4~-F~1,2~LF~3,4~C*^myc^* (*A--E*), β~4~-F~3,4~C′*^myc^* (*F--H*), or β~4~-F~1,2~L′*^myc^* (*I--K*). After ∼48 h, cells were fixed and double- or triple-stained. (*A*, *C*, *F*, and *I*), c-*myc*-tagged integrin β~4~ proteins. (*D*, *G*, and *J*), vimentin, FITC optics. (*B*, *E*, *H*, and *K*), cytokeratins, UV optics (AMCA). Focus was set for the Texas red channel. Mutant proteins containing the carboxy-terminal 267 amino acids of the β~4~ cytoplasmic tail (β~4~-F~1,2~LF~3,4~C*^myc^* and β~4~-F~3,4~C′*^myc^*) led to the collapse of both IF systems (*B*, *D*, *E*, *G*, and *H*), whereas the protein lacking this domain (β~4~-F~1,2~L′*^myc^*) did not (*J* and *K*). Bar, 15 μm.](JCB15097.f10){#F10}

![Coexpression of the amino-terminal plectin protein Ple-N~1~ and various integrin β~4~ mutant proteins in PtK2 cells. Cells plated on glass coverslips were cotransfected with a cDNA construct encoding Ple-N~1~ ^GFP^ and one of the plasmids encoding the integrin β~4~ mutants β~4~-F~1,2~LF~3,4~C*^myc^* (*A* and *B*), β~4~-F~1,2~L′*^myc^* (*C* and *D*), β~4~-F~3,4~C′*^myc^* (*E* and *F*), or β~4~-F~1,2~ *^myc^* (*G* and *H*). After ∼48 h, cells were fixed and double-stained for ectopically expressed c-*myc*-tagged integrin β~4~ proteins (*A*, *C*, *E*, and *G*; Texas red optics) and the GFP-tagged plectin protein (*B*, *D*, *F*, and *H*; FITC optics). Note colocalization of β~4~-F~1,2~LF~3,4~C*^myc^*, β~4~-F~1,2~L′*^myc^*, and β~4~-F~3,4~C′*^myc^*, but not β~4~-F~1,2~ *^myc^*, with Ple-N~1~ ^GFP^. Bar, 15 μm.](JCB15097.f8){#F8}

![Postembedding immunogold electron microscopy of plectin in rat skin (*A--C*) and schematic model highlighting plectin\'s putative role as a stabilizer of hemidesmosomes (*D*). (*A--C*) Indirect immunogold labeling of plectin molecules using antibodies specific to the rod domain (*A*; mAb 7A8, 5 nm gold), the amino terminus (*B*; antiserum E1A, 1 nm gold silver enhanced), and the carboxy terminus (*C*; antiserum 135C, 5 nm gold silver enhanced). An overview over the interface between the basal keratinocyte layer and the basement membrane showing five regularly aligned hemidesmosomes is presented in *A*, and details of the hemidesmosomal ultrastructure comprising the inner plate linked to keratin filaments, plaque, lamina lucida, lamina densa, and extracellular anchoring filaments and fibrils can be identified in the ∼60-nm-thick sections shown in *B* and *C.* Note that all three domain-specific immunoreagents were found to be reactive with basolateral components of hemidesmosomes as well as cytoplasmic keratin filaments. Also note that specific immunolabeling using antiserum E1A was weak compared to mAb 7A8 and antiserum 135C and was observed only in combination with 1 nm, but not 5 or 10 nm, colloidal gold-conjugated secondary antibodies, indicating low accessibility of amino-terminal plectin epitopes, probably because of steric hindrance. Bars, 100 nM. (*D*) In this schematic drawing of a hemidesmosome, plectin molecules are depicted to connect the plaque structure with cytokeratin filaments anchored at the inner plate in a clamp-like fashion via interaction sites located at their opposite ends. Note that plectin molecules in dimeric (two polypeptide chains arranged parallel) as well as tetrameric forms (two dimers arranged anti-parallel) could provide IF- and integrin β~4~-binding sites at opposite ends and would be able to bridge the entire cytoplasmic domain of the hemidesmosome via their ∼200-nm-long rod domains. *Hd*, hemidesmosome; *LD*, lamina densa; *kf*, keratin filaments; *Af*, anchoring filaments; *Fb*, anchoring fibrils; *IP*, inner plate; *P*, plaque; *Ple*, plectin; *M*, cell membrane; *N*, plectin amino terminus; *C*, plectin carboxy terminus.](JCB15097.f9){#F9}

![Collapse of the cytokeratin filament networks in 804G cells. Cells plated on glass coverslips were transfected with cDNA constructs encoding mutant integrin β~4~-F~1,2~LF~3,4~C*^myc^* (*A* and *B*), β~4~-F~3,4~C′*^myc^* (*C* and *D*), β~4~-F~1,2~L′*^myc^* (*E* and *F*), or β~4~-F~1,2~ *^myc^* (*G* and *H*). After 24 h, cells were fixed and double-stained. (*A*, *C*, *E*, and *G*), c-*myc*-tagged (Texas red optics) integrin β~4~ proteins. (*B*, *D*, *F*, and *H*), cytokeratin (FITC optics). Note cytokeratin filament network collapse in cells expressing β~4~-F~1,2~LF~3,4~C*^myc^* or β~4~-F~3,4~C′*^myc^* (*B* and *D*), whereas no such collapse is observed with β~4~-F~1,2~L′*^myc^* or β~4~-F~1,2~ *^myc^* (*F* and *H*). Bar, 25 μm.](JCB15097.f11){#F11}

![Immunolocalization (*A* and *B*) and Western blotting (*C*) of endogenous plectin in 804G cells. Cells were grown on glass coverslips to medium density, fixed, and double-immunostained using rabbit antibodies to integrin β~4~ (*A*) and mAb 5B3 to plectin (*B*). Note colocalization of plectin with integrin β~4~ in Swiss cheese-like patterns typical of hemidesmosomes formed by this cell line (plane of focus is just above substrate level). Insets show optical vertical sections with their starting positions indicated by arrowheads. Note localization of the bulk of integrin β~4~ as well as plectin at the basal side of the cells. Bar, 25 μm. Purified plectin from the rat glioma cell line C6 (*C*, lane *C6*) and a 804G cell lysate (*C*, lane *804G*) were analyzed by SDS-4.5% PAGE and transferred onto a nitrocellulose membrane. Plectin was detected using mAb 5B3. Molecular weight markers were as indicated (×10^−3^).](JCB15097.f12){#F12}

![Immunolocalization of plectin in 804G cells overexpressing integrin β~4~ cytoplasmic tail domain fragments. Cells grown on glass coverslips were transfected with cDNA constructs encoding integrin β~4~ mutant proteins β~4~-F~1,2~LF~3,4~C*^myc^* (*A* and *B*), β~4~-F~3,4~C′*^myc^* (*C* and *D*), β~4~-F~1,2~L′*^myc^* (*E* and *F*), or β~4~-F~1,2~ *^myc^* (*G* and *H*). Cells were fixed 8 h posttransfection and double-stained using anti-c-*myc* antibodies (*A*, *C*, *E*, and *G*) and anti-plectin mAb 5B3 (*B*, *D*, *F*, and *H*). Confocal laser scanning microscopy was used to generate extended focus images over the total height of the cells. Arrowheads indicate positions of optical vertical sections shown in insets (tips of arrowheads correspond to left hand margins of insets). Note, plectin staining is substantially diminished at hemidesmosomes of cells overexpressing β~4~-F~1,2~LF~3,4~C*^myc^*, β~4~-F~3,4~C′*^myc^*, or β~4~-F~1,2~L′*^myc^* (*B*, *D*, and *F*), but still present at such structures in cells overexpressing β~4~-F~1,2~ *^myc^* (*H*), as judged by the absence or presence of the typical hemidesmosomal staining pattern. Bar, 10 μm.](JCB15097.f13){#F13}
